BBVA
BMRN icon

Banco Bilbao Vizcaya Argentaria’s BioMarin Pharmaceuticals BMRN Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,557
Closed -$224K – 738
2024
Q1 		$224K Buy
+2,557
New +$229K ﹤0.01% 745
2023
Q4 		– Sell
-2,740
Closed -$244K – 733
2023
Q3 		$244K Buy
+2,740
New +$244K ﹤0.01% 693
2022
Q4 		– Sell
-2,747
Closed -$236K – 714
2022
Q3 		$236K Sell
2,747
-1,170
-30% -$104K ﹤0.01% 686
2022
Q2 		$325K Buy
+3,917
New +$312K ﹤0.01% 622
2022
Q1 		– Sell
-3,322
Closed -$296K – 716
2021
Q4 		$296K Sell
3,322
-74,512
-96% -$6.15M ﹤0.01% 736
2021
Q3 		$6.03M Sell
77,834
-119,174
-60% -$9.4M 0.09% 187
2021
Q2 		$16.4M Buy
197,008
+30,294
+18% +$2.4M 0.29% 63
2021
Q1 		$12.6M Buy
166,714
+58,662
+54% +$4.79M 0.25% 81
2020
Q4 		$9.47M Sell
108,052
-18,955
-15% -$1.5M 0.22% 88
2020
Q3 		$9.66M Buy
127,007
+105,088
+479% +$10.6M 0.28% 60
2020
Q2 		$2.7M Buy
21,919
+18,079
+471% +$1.8M 0.09% 194
2020
Q1 		$324K Buy
+3,840
New +$331K 0.01% 561

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Banco Bilbao Vizcaya Argentaria's BMRN Position: Q2 2024 in Review

Banco Bilbao Vizcaya Argentaria sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2024, closing a stake of 2,557 shares — an estimated $224K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in BMRN in Q1 2020 and held it in 12 quarters. The position peaked at $16.4M in Q2 2021. 559 funds tracked by Wall St. Rank hold BMRN as of Q2 2024.

  • Banco Bilbao Vizcaya Argentaria reported no remaining BioMarin Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 2,557 BioMarin Pharmaceuticals shares in Q2 2024, an estimated $224K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in BioMarin Pharmaceuticals in Q1 2020 and held it in 12 quarters.
  • Banco Bilbao Vizcaya Argentaria's BioMarin Pharmaceuticals position peaked at $16.4M in Q2 2021.
  • 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2024.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2024, filed 6 Aug 2024.